Is Alphabet Stock No Longer a Good Bet?
Alphabet tripled its price per share over the past 5…
Sell
25
ACDC Quote, Financials, Valuation and Earnings
Last price:
$7.68
Seasonality move
:
-8.06%
Day range:
$6.90 - $7.28
52-week range:
$5.16 - $9.75
Dividend yield:
0%
P/E ratio:
8.77x
P/S ratio:
0.52x
P/B ratio:
1.13x
Volume:
397.1K
Avg. volume:
504.2K
1-year change:
-8.82%
Market cap:
$1.1B
Revenue:
$2.2B
EPS (TTM):
-$1.36
Analysts' Opinion
-
Consensus RatingProFrac Holding has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 4 Hold ratings, and 1 Sell rating.
-
Price Target UpsideAccording to analysts' consensus price target of $7.40, ProFrac Holding has an estimated upside of 3.79% from its current price of $7.13.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $7.00 representing 1.82% downside risk from its current price of $7.13.
Fair Value
-
According to the consensus of 5 analysts, ProFrac Holding has 3.79% upside to fair value with a price target of $7.40 per share.
ACDC vs. S&P 500
-
Over the past 5 trading days, ProFrac Holding has underperformed the S&P 500 by -2.97% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
ProFrac Holding does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
ProFrac Holding revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter ProFrac Holding reported revenues of $454.7M.
Earnings Growth
-
ProFrac Holding has grown year-over-year earnings for 0 quarters straight. In the most recent quarter ProFrac Holding reported earnings per share of -$0.66.
Enterprise value:
2.3B
EV / Invested capital:
1.06x
Price / LTM sales:
0.52x
EV / EBIT:
59.63x
EV / Revenue:
1.05x
PEG ratio (5yr expected):
-0.02x
EV / Free cash flow:
20.53x
Price / Operating cash flow:
10.16x
Enterprise value / EBITDA:
6.00x
Gross Profit (TTM):
$253.6M
Return On Assets:
-7%
Net Income Margin (TTM):
-9.82%
Return On Equity:
-17.93%
Return On Invested Capital:
-9.28%
Operating Margin:
-9.72%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $2.4B | $2.6B | $2.2B | $489.1M | $454.7M | |
| Gross Profit | $701.5M | $459.6M | $253.6M | $46.7M | $3.8M | |
| Operating Income | $461.3M | $217.8M | $39.4M | -$900K | -$44.2M | |
| EBITDA | $678.6M | $535.3M | $384M | $41.6M | $68.3M | |
| Diluted EPS | $1.99 | -$0.40 | -$1.36 | -$0.61 | -$0.66 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | $251.7M | $865.4M | $638.1M | $574.1M | |
| Total Assets | -- | $664.6M | $2.9B | $3.1B | $3B | |
| Current Liabilities | -- | $246.7M | $683.9M | $648.9M | $660M | |
| Total Liabilities | -- | $516.5M | $1.6B | $1.8B | $1.9B | |
| Total Equity | -- | $148.1M | $1.4B | $1.3B | $1.1B | |
| Total Debt | -- | $301.6M | $925.4M | $1.1B | $1.1B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $415.2M | $553.5M | $367.3M | $42.7M | $76.5M | |
| Cash From Investing | -$1B | -$715.8M | -$372.3M | -$28.4M | -$20.5M | |
| Cash From Financing | $645.9M | $149.7M | -$5.5M | -$14.8M | -$66.7M | |
| Free Cash Flow | $59M | $286.5M | $112.3M | $9.6M | $13.3M | |
ACDC
Sector
Market Cap
$1.1B
$59.2M
Price % of 52-Week High
73.13%
59.47%
Dividend Yield
0%
0%
Shareholder Yield
--
4.67%
1-Year Price Total Return
-8.82%
-22.79%
Beta (5-Year)
--
1.027
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$7.13
200-day SMA
Sell
Level
$7.37
Bollinger Bands (100)
Sell
Level
6.58 - 8.26
Chaikin Money Flow
Sell
Level
-1.8M
20-day SMA
Sell
Level
$7.17
Relative Strength Index (RSI14)
Sell
Level
47.67
ADX Line
Sell
Level
11.44
Williams %R
Neutral
Level
-42.4661
50-day SMA
Sell
Level
$7.66
MACD (12, 26)
Sell
Level
-0.14
25-day Aroon Oscillator
Sell
Level
-40
On Balance Volume
Neutral
Level
10.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.914)
Sell
CA Score
(Annual)
Level (-0.8827)
Buy
Beneish M-Score
(Annual)
Level (-3.2428)
Buy
Momentum Score
Level (4)
Sell
Ohlson Score
Level (0.8579)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (1)
Sell
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
Stock Forecast FAQ
In the current month, ACDC has received 0 Buy ratings 4 Hold ratings, and 1 Sell ratings. The ACDC average analyst price target in the past 3 months is $7.40.
-
Where Will ProFrac Holding Stock Be In 1 Year?
According to analysts, the consensus estimate is that ProFrac Holding share price will rise to $7.40 per share over the next 12 months.
-
What Do Analysts Say About ProFrac Holding?
Analysts are divided on their view about ProFrac Holding share price and where it will be in the next 12 months. The majority of analysts rate the stock a Sell. However, a smaller subset of analysts suggest that ProFrac Holding is a Buy and believe this share price will drop from its current level to $8.00.
-
What Is ProFrac Holding's Price Target?
The price target for ProFrac Holding over the next 1-year time period is forecast to be $7.40 according to 5 Wall Street analysts, 0 of them rate the stock a Buy, 1 rates the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is ACDC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for ProFrac Holding is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of ACDC?
You can purchase shares of ProFrac Holding via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase ProFrac Holding shares.
-
What Is The ProFrac Holding Share Price Today?
ProFrac Holding was last trading at $7.68 per share. This represents the most recent stock quote for ProFrac Holding. Yesterday, ProFrac Holding closed at $7.13 per share.
-
How To Buy ProFrac Holding Stock Online?
In order to purchase ProFrac Holding stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Pepsi Vs Coke Stock: Which Is Best?
Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…
Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Stock Ideas
Buy
52
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 39x
Alerts
Buy
52
RGC alert for Mar 19
Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.
Sell
49
SRPT alert for Mar 19
Sarepta Therapeutics [SRPT] is up 8.72% over the past day.
Sell
46
CVNA alert for Mar 19
Carvana [CVNA] is up 5.74% over the past day.
